Home » News » 01/06 » Takeda sells vitamin stake to BASF

Takeda sells vitamin stake to BASF

Date published: 06/01/2006

Takeda Pharmaceutical has transferred all its shares in the joint venture BASF Takeda Vitamin (BTV) to partner BASF Japan. The transfer, for an undisclosed sum, follows the joint venture agreement that established the firm in January 2001 when the vitamin bulk business of both companies were transferred and combined in BTV.

Under the initial agreement BASF Japan held 66 per cent of stock and Takeda took 34 per cent. Yasuchika Hasegawa, Takeda president and chief operating officer, said: "Our former bulk vitamin business has been successfully transferred to BTV.

"We believe that BASF Japan will maintain the leading position in bulk vitamin business in Japan with enough competitive business foundations."

Since the forming of BTV it has expanded to become one of Japan's major suppliers of bulk vitamins, premixes and pharmaceutical excipients.

© Adfero Ltd

Disclaimer

AllAboutMedicalSales excludes any warranty, express or implied, as to the quality, accuracy, timeliness, completeness or fitness for a particular purpose of this briefing. AllAboutMedicalSales will not be liable for any claims, penalties, losses, damages, costs, or expenses arising from the use of or inability to use this briefing or from any unauthorised access to or alteration of the Briefing. AllAboutMedicalSales makes no warranty that the contents of this briefing are compatible with all computer systems and browsers.